Loading…
Loading…
Axon (AXON) reported earnings 30 days ago. What's next for the stock?
AXON's Connected Devices revenues surge 34.6%, fueled by TASER 10, counter-drone equipment and strong international bookings.
During the quarter, we initiated a position in Advanced Drainage Systems, the leading U.S. manufacturer of stormwater and onsite wastewater management products. We view Axon Enterprise as a market leading "atoms plus electrons" software provider with huge competitive moats. We sold the HeartFlow position in the quarter as we grew incrementally more concerned with the presence of competitors on the market.
The transaction involved the disposal of 16,775 shares on Aug. 31, 2026, for a total value of ~$9.6 million. The traded shares represented 5% of the direct equity stake held before the filing.
On Sept. 1, 2026, rising crude and Treasury yields pressured equities across nearly every sector, with tech stocks bearing the brunt of the selloff.
Shares of Axon Enterprise Inc. (NASDAQ:AXON) are sliding Tuesday afternoon, dropping nearly 8% to hover near $522 after falling over 5% during Monday's session.
Axon's Dedrone C2 upgrades, strategic partnerships and rising CUAS demand are fueling momentum after revenues topped $100 million in Q2 2026.
Bamco Inc. NY acquired a new stake in shares of Axon Enterprise, Inc (NASDAQ: AXON) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 153,615 shares of the biotechnology company's stock, valued at approximately $86,118,000. Bamco Inc. NY owned about 0.19% of